Omnicare (OCR) Shares Down 7+%; JPMorgan Says Buy the Dip
Tweet Send to a FriendGet Alerts OCR Hot Sheet
Price: $46.15 --0%
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 8 | New: 6
Rating Summary:
2 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 8 | New: 6
Trade OCR Now!
With shares of Omnicare (NYSE: OCR) down more than 7 percent Monday afternoon following unexpected news the company's CEO Figueroa has resigned, JPMorgan's Lisa Gill is telling investors to buy the weakness.
The analyst pointed out Omnicare already has a turnaround plan in place and will probably not make any major changes even with new management. Moreover, Gill said she was optimistic about the promotion of John Workman as interim CEO, as well as Nitin Sahney being named the new COO. The JPMorgan analyst noted Figueroa's resignation was related to personal reasons.
JPMorgan's Gill maintains an Overweight rating and $41 price target on shares of Omnicare. With the stock last trading around $30.92, Gill's price target represents potential upside of about 33 percent.
To track all the market-moving analyst action on shares of Omnicare, visit our Analyst Ratings page.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The analyst pointed out Omnicare already has a turnaround plan in place and will probably not make any major changes even with new management. Moreover, Gill said she was optimistic about the promotion of John Workman as interim CEO, as well as Nitin Sahney being named the new COO. The JPMorgan analyst noted Figueroa's resignation was related to personal reasons.
JPMorgan's Gill maintains an Overweight rating and $41 price target on shares of Omnicare. With the stock last trading around $30.92, Gill's price target represents potential upside of about 33 percent.
To track all the market-moving analyst action on shares of Omnicare, visit our Analyst Ratings page.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Shorts Buried in MLM Companies (HLF) (USNA) (NUS)
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
- Dougherty & Co Raises PT on SodaStream (SODA) to $80
Create E-mail Alert Related Categories
Analyst Comments, Momentum MoversRelated Entities
JPMorgan
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
